Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.
This study, published June 6 by Nature, marks the first demonstration in a living system that OxPL triggers inflammation and leads to plaque formation. The results also suggest a new approach for preventing or reversing a number of inflammatory diseases.
“Wherever you get inflammation, you get OxPL,” said senior author Joseph Witztum, MD, professor of medicine at UC San Diego School of Medicine. “It doesn’t mean OxPL is the cause, but it definitely plays a major role.” Witztum led the study with first author Xuchu Que, PhD, a senior project scientist at UC San Diego School of Medicine.
Some phospholipids — the molecules that make up cell membranes — are prone to modification by reactive oxygen species, forming OxPL. This event is particularly common in inflammatory conditions such as atherosclerosis, in which artery-blocking plaques form. Prior to this study, researchers were unable to control phospholipid oxidation in a way that would allow them to study its role in inflammation and atherosclerosis.
Witztum, Que and team engineered mice with two special attributes: 1) they have a gene mutation that makes them a good model for atherosclerosis and 2) they generate a piece of an antibody called E06 that’s just enough to bind OxPL and prevent their ability to cause inflammation in immune cells, but not enough to cause inflammation on its own. They fed the mice a high-fat diet.
Here’s what happened: Compared to control mice, the mice with E06 antibodies had 28 to 57 percent less atherosclerosis, even after one year and despite having high levels of cholesterol. The antibody also decreased aortic valve calcification (hardening and narrowing of the aortic valves), hepatic steatosis (fatty liver disease) and liver inflammation. E06 antibody-producing mice had 32 percent less serum amyloid A, a marker of systemic inflammation.
The E06 antibody also prolonged the life of the mice. After 15 months, all of the E06 antibody-producing mice were alive, compared to 54 percent of the control mice.
“We showed for the first time that OxPL are truly pro-inflammatory and pro-atherogenic and, moreover, that they can be counteracted by E06 antibody,” Witztum said. “This suggests that therapies that inactivate OxPL may be beneficial for reducing inflammation in general, and in particular in the case of diseases such as atherosclerosis, aortic stenosis and hepatic steatosis.”
Witztum and team are now testing E06 antibody in mouse models of human diseases linked to inflammation, such as osteoporosis (bone loss) and nonalcoholic steatohepatitis (NASH, a type of liver disease).
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- Report: 'At least' 5 Big Ten athletes found to have type of heart inflammation potentially caused by viral infectionson August 10, 2020 at 3:51 pm
The cases of myocarditis are reportedly a reason why Big Ten officials have weighed not playing football and other fall sports in 2020.
- Dietary interventions to optimize healing of injury-induced inflammationon August 10, 2020 at 2:50 pm
Injuries induce the initiation of inflammation to control the damage. However, the resolution of the injury-induced inflammation leading to healing is not well characterized.
- Dodgers Place Joe Kelly On IL With Shoulder Inflammationon August 10, 2020 at 1:23 pm
The Dodgers placed right-handed reliever Joe Kelly on the 10-day injured list with shoulder inflammation this morning and recalled left-hander Adam Kolarek from their alternate training site.
- Researchers characterize important regulators of tissue inflammation, fibrosis and regenerationon August 10, 2020 at 12:00 pm
Although macrophages (cells involved in the detection and destruction of bacteria and other harmful organisms as well as dead cells) are classified as immune cells functioning in the activation and ...
- Dodgers reliever Joe Kelly placed on injured list with shoulder inflammationon August 10, 2020 at 11:20 am
The Dodgers placed Joe Kelly on the injured list Monday because of shoulder inflammation. They recalled left-hander Adam Kolarek to take Kelly's spot.
- Los Angeles Dodgers reliever Joe Kelly goes on IL with shoulder inflammationon August 10, 2020 at 10:24 am
Joe Kelly, the Los Angeles Dodgers ' hard-throwing reliever, has been placed on the injured list with inflammation in his right shoulder, adding to the mounting list of injuries suffered by pitchers ...
- Dodgers' Joe Kelly: Out with shoulder inflammationon August 10, 2020 at 10:08 am
Kelly landed on the 10-day injured list with shoulder inflammation Monday. The Dodgers were already likely to be without Kelly for some time, as the hearing on his appeal of the eight-game suspension ...
- Rays place Charlie Morton on injured list with shoulder inflammationon August 10, 2020 at 9:21 am
Rays right-hander Charlie Morton will miss at least one start after leaving Sunday’s game in the third inning with inflammation in his right throwing shoulder. The team placed the 36-year-old on the ...
- Rays put ace Charlie Morton on IL with shoulder inflammationon August 10, 2020 at 8:18 am
The Rays have placed ace Charlie Morton on the 10-day injured list with inflammation in his pitching shoulder.
via Bing News